XML 58 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Organization - Additional Information (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2020
Nov. 30, 2020
USD ($)
Dec. 31, 2023
USD ($)
platform
shares
Jun. 30, 2023
Jan. 31, 2023
Dec. 31, 2022
USD ($)
Organization Consolidation And Presentation Of Financial Statements [Line Items]            
Number of technology platforms | platform     2      
Aggregate offering price   $ 300,000        
Accumulated deficit     $ 237,824     $ (377,237)
Cash, cash equivalents and investments     $ 1,630,000      
Encentrio Therapeutics, Inc.            
Organization Consolidation And Presentation Of Financial Statements [Line Items]            
Equity method ownership percentage       100.00%    
Encentrio Therapeutics, Inc.            
Organization Consolidation And Presentation Of Financial Statements [Line Items]            
Ownership percentage         80.00%  
Common Stock | Sales Agreement            
Organization Consolidation And Presentation Of Financial Statements [Line Items]            
Issuance of common stock (in shares) | shares     0      
Common Stock | Sales Agreement | Maximum            
Organization Consolidation And Presentation Of Financial Statements [Line Items]            
Percentage of commission rate from sale of shares 3.00%